• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Schering-Plough

Schering-Plough

Merck & Co Inc MRK 4 Star

Last Price$54.05Day Change (%)0.06%
Open Price$54.22Day Change ($)0.03
Day Range53.92–54.2752-Week Range44.62–61.33

As of Mon 10/20/2014 04:13 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  5. Research
  1. Research and Markets: Uveitis Market Analysis 2014-2015 - API Manufacturers and Phase III Pipeline Assessment

    Research and Markets: Uveitis Market Analysis 2014-2015 - API Manufacturers and Phase III Pipeline Assessment

  2. PDI, Inc. Announces Appointment of Graham G. Miao, MBA, Ph.D. as Chief Financial Officer

    PDI, Inc. Announces Appointment of Graham G. Miao, MBA, Ph.D. as Chief Financial Officer

  3. Allied-Bristol Life Sciences Appoints Former Bristol-Myers Vice President Satish Jindal to Lead the Discovery of Drug Candidates From Leading Academic Institutions

    Allied-Bristol Life Sciences Appoints Former Bristol-Myers Vice President Satish Jindal to Lead the Discovery of Drug Candidates From Leading Academic Institutions

  4. NephroGenex Appoints Marco Taglietti, M.D. to Board of Directors

    NephroGenex Appoints Marco Taglietti, M.D. to Board of Directors

  5. High-Priced Sale of Consumer Business Strengthens This Big Pharma Firm's Moat

    The sale to Bayer monetizes Merck's consumer unit at a strong valuation, and removes Merck from an area where it lacks scale.

  6. Contrarian Buying at American Funds

    American's managers have been busy buying unloved large caps.

  7. Australia stocks fall ahead of China data

    Australia stocks fall ahead of China data

  8. Light and Landis+Gyr unveil largest smart grid partnership in South America

    Light and Landis+Gyr unveil largest smart grid partnership in South America

  9. Homestead Value

    With a rock-solid belief in their strategy, the managers of Homestead Value confidently go about their business.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.